JP2021502951A5 - - Google Patents

Download PDF

Info

Publication number
JP2021502951A5
JP2021502951A5 JP2019538254A JP2019538254A JP2021502951A5 JP 2021502951 A5 JP2021502951 A5 JP 2021502951A5 JP 2019538254 A JP2019538254 A JP 2019538254A JP 2019538254 A JP2019538254 A JP 2019538254A JP 2021502951 A5 JP2021502951 A5 JP 2021502951A5
Authority
JP
Japan
Prior art keywords
vlp
composition
pentamer
delivery system
drug delivery
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2019538254A
Other languages
English (en)
Japanese (ja)
Other versions
JP6884432B2 (ja
JP2021502951A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2018/085699 external-priority patent/WO2020125962A1/en
Publication of JP2021502951A publication Critical patent/JP2021502951A/ja
Publication of JP2021502951A5 publication Critical patent/JP2021502951A5/ja
Application granted granted Critical
Publication of JP6884432B2 publication Critical patent/JP6884432B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2019538254A 2018-12-18 2018-12-18 新規薬物送達システムおよびそれを提供する方法 Expired - Fee Related JP6884432B2 (ja)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/EP2018/085699 WO2020125962A1 (en) 2018-12-18 2018-12-18 A novel drug delivery system and methods providing thereof

Publications (3)

Publication Number Publication Date
JP2021502951A JP2021502951A (ja) 2021-02-04
JP2021502951A5 true JP2021502951A5 (https=) 2021-04-30
JP6884432B2 JP6884432B2 (ja) 2021-06-09

Family

ID=65009711

Family Applications (3)

Application Number Title Priority Date Filing Date
JP2019538254A Expired - Fee Related JP6884432B2 (ja) 2018-12-18 2018-12-18 新規薬物送達システムおよびそれを提供する方法
JP2019227342A Pending JP2020105169A (ja) 2018-12-18 2019-12-17 リソソーム蓄積症の処置のためのvlp
JP2022521659A Pending JP2022551531A (ja) 2018-12-18 2020-10-13 John CunninghamウイルスVLPを提供するための方法

Family Applications After (2)

Application Number Title Priority Date Filing Date
JP2019227342A Pending JP2020105169A (ja) 2018-12-18 2019-12-17 リソソーム蓄積症の処置のためのvlp
JP2022521659A Pending JP2022551531A (ja) 2018-12-18 2020-10-13 John CunninghamウイルスVLPを提供するための方法

Country Status (12)

Country Link
US (4) US11279938B2 (https=)
EP (2) EP3688147B8 (https=)
JP (3) JP6884432B2 (https=)
CN (3) CN111587289B (https=)
BR (3) BR112019014209A2 (https=)
CA (3) CA3049197C (https=)
DK (1) DK3688147T3 (https=)
ES (1) ES2933275T3 (https=)
HU (1) HUE060952T2 (https=)
PL (1) PL3688147T3 (https=)
SI (1) SI3688147T1 (https=)
WO (4) WO2020125962A1 (https=)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2023526528A (ja) * 2020-05-22 2023-06-21 ノイウェイ ファルマ ゲーエムベーハー 白質ジストロフィーの処置のためのvlp
WO2022227287A1 (zh) * 2021-04-25 2022-11-03 中南大学 Dnj及其衍生物在制备预防和/或治疗肺动脉高压药物中的应用
CN115448980A (zh) * 2021-06-08 2022-12-09 戴德森医疗财团法人嘉义基督教医院 表面链结标靶多肽的类病毒颗粒及其用途
EP4166672A1 (en) 2021-10-15 2023-04-19 NEUWAY Pharma GmbH A novel method for purification of protein- or peptide-based capsules
CN116554279A (zh) * 2022-01-28 2023-08-08 思凯生科有限公司 包含有专一性表达于前列腺细胞的表达质粒的类病毒颗粒及其用途
WO2024079361A1 (en) 2022-10-14 2024-04-18 Neuway Pharma Gmbh A PROTEIN- OR PEPTIDE-BASED CAPSULE (PPC), PREFERABLY A VLP, LOADED WITH A MESSENGER RNA (mRNA) AND A METHOD OF PRODUCTION AND PURIFICATION THEREOF

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19543553B4 (de) 1995-11-22 2009-04-09 Deutsches Primatenzentrum Gmbh VP-Antigene des JC-Virus
AU2003222568B2 (en) 2002-01-11 2009-05-07 Bioasis Technologies, Inc. Use of P97 as an enzyme delivery system for the delivery of therapeutic lysosomal enzymes
US7442372B2 (en) 2003-08-29 2008-10-28 Biomarin Pharmaceutical Inc. Delivery of therapeutic compounds to the brain and other tissues
FR2920158B1 (fr) 2007-08-24 2010-03-12 Centre Nat Rech Scient Production de plasmides et expression de proteines recombinantes dans des cellules cultivees sans antibiotiques
EP2554664A1 (de) 2011-08-02 2013-02-06 Life Science Inkubator Verfahren zur Aufreinigung von Virus-ähnlichen Partikeln (VLP)
EP2636746A1 (en) 2012-03-06 2013-09-11 Life Science Inkubator A novel drug delivery system based on JCV-VLP
AR100419A1 (es) * 2014-05-14 2016-10-05 Esteve Labor Dr Vectores de virus adenoasociados para el tratamiento de trastornos de almacenamiento lisosómico

Similar Documents

Publication Publication Date Title
JP2021502951A5 (https=)
JP7447176B2 (ja) ジクアホソル含有点眼液
DE60020570T2 (de) Rotavirus impfstoffformulierungen
CN1263508C (zh) 活疫苗的稳定剂
JP2007535948A5 (https=)
JP2018503595A5 (https=)
RU2484847C2 (ru) Лиофилизированный препарат, содержащий гриппозную вакцину, и способ его получения
JP2016520075A5 (https=)
UA127829C2 (uk) Стабільна ліофілізована імуногенна композиція, яка містить живий атенуйований рекомбінантний флавівірус, спосіб і набір для її отримання та застосування
DE69738271T2 (de) Rotavirus-impfstoff
WO2012090994A1 (ja) ジクアホソル含有点眼液およびその製造方法、不溶性析出物発生の抑制方法
JP2017525679A5 (https=)
JPS6314729A (ja) 生ワクチン用改良安定剤、その製造法およびそれを含有するワクチン
JPH06234659A (ja) 安定化生ワクチン
JP4558652B2 (ja) ウイルス生産の改善
CN110845636B (zh) 一种去除细菌多糖中的内毒素的方法
KR20150116854A (ko) 바이러스―유사 입자의 방출 방법
JP7037811B2 (ja) スフェロイド形成促進剤の精製方法
JPWO2021168100A5 (https=)
JP2017079791A5 (https=)
JP2926722B2 (ja) アルブミン製剤及びその製造方法
CN103169978B (zh) 用于禽免疫球蛋白的温控缓释注射剂、其制备方法及其应用
JP2016084329A (ja) 振とうストレス耐性を有するタンパク質の水性懸濁剤
AU2008202660B2 (en) Rotavirus vaccine formulations
US20240229007A1 (en) Inactivated vaccines & nucleic acid aptamer therapeutics derived therefrom